Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences
He spoke to Pharma IQ about his recent report on Epigenetic research classes and Assay Trends with Genetic Engineering & Biotechnology News (GEN)
[inlinead]
Insights from the world’s foremost thought leaders delivered to your inbox.
2022-10-18
02:00 PM - 03:00 PM BST
Join us to hear from the most influential people in pharma today, as voted for by you
2022-06-01
04:30 PM - 05:30 PM CET
In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...
2022-04-28
01:00 PM - 02:00 PM EST
This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...
